GMP Update: Reducing Obstacles to Innovation

October 2, 2003
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor,

Pharmaceutical Technology, Pharmaceutical Technology-10-02-2003, Volume 27, Issue 10

FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.